Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers

Area of Science:

• Nephrology
• Biomarker Discovery
• Clinical Diagnostics

Background:

• Chronic kidney disease (CKD) is a global health issue requiring effective management strategies.
• Accurate diagnosis, prognosis, and therapeutic assessment are crucial for CKD patient care.
• Existing CKD biomarkers often lack comprehensive validation or clinical implementation guidance.

Purpose of the Study:

• To provide a comprehensive overview of non-invasive biomarkers for CKD management.
• To identify biomarkers with demonstrated clinical utility in prospective studies.
• To offer guidance on the application of these biomarkers in clinical practice.

Main Methods:

• Systematic review of published literature on CKD biomarkers.
• Focus on non-invasive biomarkers with evidence from prospective studies or large sample sizes (>=100 subjects).
• Compilation and synthesis of data on diagnostic, prognostic, and predictive biomarker utility.

Main Results:

• Several validated non-invasive biomarkers show potential for CKD management.
• Evidence supports the clinical value of specific biomarkers in diagnosing and predicting CKD progression.
• The review identifies biomarkers with demonstrated added value in patient care.

Conclusions:

• Non-invasive biomarkers are increasingly available and valuable for effective CKD management.
• Further research and clinical validation are essential to optimize biomarker use.
• This review provides a foundation for applying evidence-based biomarkers in CKD care.